A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors
Clinical trial NCT04175847 · COMPLETED
Trial details
- NCT number
- NCT04175847
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-14
- Primary completion
- 2025-12-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.